Different thermodynamic binding mechanisms and peptide fine specificities associated with a panel of structurally similar high-affinity T cell receptors.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 2680728)

Published in Biochemistry on November 25, 2008

Authors

Lindsay L Jones1, Leremy A Colf, Alexander J Bankovich, Jennifer D Stone, Yi-Gui Gao, Choi Mui Chan, Raven H Huang, K Christopher Garcia, David M Kranz

Author Affiliations

1: Department of Biochemistry and School of Chemical Sciences Biocrystallization Service, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.

Articles citing this

Functional implications of T cell receptor diversity. Curr Opin Immunol (2009) 1.13

Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity. Mol Immunol (2009) 0.99

Diversity-oriented approaches for interrogating T-cell receptor repertoire, ligand recognition, and function. Immunol Rev (2012) 0.98

Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors. Protein Eng Des Sel (2010) 0.98

Computational design of the affinity and specificity of a therapeutic T cell receptor. PLoS Comput Biol (2014) 0.96

TCR scanning of peptide/MHC through complementary matching of receptor and ligand molecular flexibility. J Immunol (2014) 0.94

The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule. J Biol Chem (2012) 0.91

Methods for quantifying T cell receptor binding affinities and thermodynamics. Methods Enzymol (2009) 0.84

The effect of mutations on the alloreactive T cell receptor/peptide-MHC interface structure: a molecular dynamics study. J Phys Chem B (2011) 0.82

Relaxation estimation of RMSD in molecular dynamics immunosimulations. Comput Math Methods Med (2012) 0.79

Design and characterization of a protein superagonist of IL-15 fused with IL-15Rα and a high-affinity T cell receptor. Biotechnol Prog (2012) 0.78

Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy. Arch Immunol Ther Exp (Warsz) (2010) 0.78

The same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld system. J Biol Chem (2013) 0.77

Subtle changes in TCRα CDR1 profoundly increase the sensitivity of CD4 T cells. Mol Immunol (2012) 0.77

Articles cited by this

Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01

Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28

Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63

PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr (2002) 53.61

How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 7.57

A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today (1998) 5.07

Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science (1998) 3.64

How a single T cell receptor recognizes both self and foreign MHC. Cell (2007) 3.20

Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity (2003) 3.04

Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat Immunol (2001) 2.83

Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol Cell (2003) 2.61

Interface-disrupting amino acids establish specificity between T cell receptors and complexes of major histocompatibility complex and peptide. Nat Immunol (2006) 2.57

A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol (2007) 2.55

Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc Natl Acad Sci U S A (1984) 2.54

Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity (1994) 2.39

The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition. Nat Immunol (2005) 2.38

TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity (1999) 2.33

The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity (2008) 2.31

Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J Exp Med (2000) 2.18

TCRs with high affinity for foreign pMHC show self-reactivity. Nat Immunol (2002) 2.12

CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat Immunol (2003) 2.10

High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci U S A (1994) 2.09

T cell cross-reactivity and conformational changes during TCR engagement. J Exp Med (2004) 1.99

In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc Natl Acad Sci U S A (2000) 1.92

Alanine scanning mutagenesis of an alphabeta T cell receptor: mapping the energy of antigen recognition. Immunity (1998) 1.80

Directed evolution of a stable scaffold for T-cell receptor engineering. Nat Biotechnol (2000) 1.76

Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc Natl Acad Sci U S A (1997) 1.67

A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. Proc Natl Acad Sci U S A (1993) 1.63

How the T cell receptor sees antigen--a structural view. Cell (2005) 1.58

Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes. Biochem J (2008) 1.56

Kinetics and thermodynamics of T cell receptor- autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2001) 1.56

Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand. J Mol Biol (2005) 1.55

Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning. Proc Natl Acad Sci U S A (1999) 1.47

How much can a T-cell antigen receptor adapt to structurally distinct antigenic peptides? EMBO J (2007) 1.44

CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. J Exp Med (2001) 1.38

Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci (2006) 1.31

Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor. Proc Natl Acad Sci U S A (2001) 1.30

High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J Mol Biol (2004) 1.21

Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface. Biochemistry (2000) 1.14

Engineering and characterization of a stabilized alpha1/alpha2 module of the class I major histocompatibility complex product Ld. J Biol Chem (2006) 1.12

Disparate thermodynamics governing T cell receptor-MHC-I interactions implicate extrinsic factors in guiding MHC restriction. Proc Natl Acad Sci U S A (2006) 1.12

Distinct molecular mechanisms account for the specificity of two different T-cell receptors. Biochemistry (2003) 1.12

Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientation. J Immunol (2008) 1.12

High-level bacterial secretion of single-chain alphabeta T-cell receptors. J Immunol Methods (2005) 1.11

Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants. J Mol Biol (2005) 1.03

A residue in the center of peptide QL9 affects binding to both Ld and the T cell receptor. J Immunol (1996) 1.00

Kinetic evidence for a ligand-binding-induced conformational transition in the T cell receptor. Proc Natl Acad Sci U S A (2007) 0.98

Role of CD8 in staphylococcal enterotoxin B-mediated lysis by cytotoxic T lymphocytes. J Immunol (1993) 0.82

Articles by these authors

STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell (2009) 6.92

Structural basis of Wnt recognition by Frizzled. Science (2012) 4.31

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J Exp Med (2011) 4.02

Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell (2008) 3.72

Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science (2013) 3.59

Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell (2009) 3.46

Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies. Science (2013) 3.25

How a single T cell receptor recognizes both self and foreign MHC. Cell (2007) 3.20

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J Exp Med (2007) 3.15

Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity (2003) 3.04

Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science (2003) 2.87

Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'. Nat Immunol (2007) 2.78

Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science (2005) 2.64

Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol Cell (2003) 2.61

Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron (2007) 2.54

Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature (2013) 2.49

Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature (2002) 2.45

Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell (2011) 2.39

An extracellular interactome of immunoglobulin and LRR proteins reveals receptor-ligand networks. Cell (2013) 2.36

Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science (2004) 2.32

Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22. Science (2005) 2.32

Structural biology of shared cytokine receptors. Annu Rev Immunol (2009) 2.27

Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc Natl Acad Sci U S A (2005) 2.27

Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell (2013) 2.18

Antigen recognition determinants of gammadelta T cell receptors. Science (2005) 2.14

TCRs with high affinity for foreign pMHC show self-reactivity. Nat Immunol (2002) 2.12

Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor. Nat Struct Mol Biol (2005) 2.12

Structure of the measles virus hemagglutinin. Nat Struct Mol Biol (2007) 2.11

Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Nature (2012) 2.08

Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron (2003) 2.06

A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron (2005) 2.03

Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity (2005) 2.03

Chemical trapping and crystal structure of a catalytic tRNA guanine transglycosylase covalent intermediate. Nat Struct Biol (2003) 1.92

Membrane fission reactions of the mammalian ESCRT pathway. Annu Rev Biochem (2013) 1.91

Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance. Proc Natl Acad Sci U S A (2010) 1.89

T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. Immunity (2011) 1.86

T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med (2009) 1.86

T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology (2009) 1.85

Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2. Structure (2010) 1.79

Graded expression of semaphorin-1a cell-autonomously directs dendritic targeting of olfactory projection neurons. Cell (2007) 1.77

Time-dependent, protein-directed growth of gold nanoparticles within a single crystal of lysozyme. Nat Nanotechnol (2011) 1.77

Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation. J Am Chem Soc (2009) 1.75

Specificity and degeneracy of T cells. Mol Immunol (2004) 1.71

Structural basis of affinity maturation and intramolecular cooperativity in a protein-protein interaction. Structure (2005) 1.70

Expression profiling using a hexamer-based universal microarray. Nat Biotechnol (2004) 1.69

Polyspecificity of T cell and B cell receptor recognition. Semin Immunol (2007) 1.68

Rationally tuning the reduction potential of a single cupredoxin beyond the natural range. Nature (2009) 1.68

Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain. Science (2008) 1.67

Deconstructing the form and function of the TCR/CD3 complex. Immunity (2006) 1.64

Structural snapshots of full-length Jak1, a transmembrane gp130/IL-6/IL-6Rα cytokine receptor complex, and the receptor-Jak1 holocomplex. Structure (2011) 1.63

Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection. Blood (2013) 1.63

The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol (2012) 1.63

Structural basis of receptor sharing by interleukin 17 cytokines. Nat Immunol (2009) 1.60

Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB. Chem Biol (2010) 1.60

Rational design of a structural and functional nitric oxide reductase. Nature (2009) 1.60

Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat Immunol (2003) 1.54

BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies. Protein Expr Purif (2008) 1.53

Noble metals strip peptides from class II MHC proteins. Nat Chem Biol (2006) 1.53

The structure of interleukin-2 complexed with its alpha receptor. Science (2005) 1.53

Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. J Exp Med (2013) 1.53

Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med (2007) 1.52

Staphylococcal toxic shock syndrome erythroderma is associated with superantigenicity and hypersensitivity. Clin Infect Dis (2009) 1.47

Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au. Immunity (2002) 1.47

Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proc Natl Acad Sci U S A (2005) 1.46

Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. J Clin Invest (2014) 1.45

Reconstituting bacterial RNA repair and modification in vitro. Science (2009) 1.45

Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat Immunol (2012) 1.41

Equilibrium between host and cancer caused by effector T cells killing tumor stroma. Cancer Res (2008) 1.39

Mutations in WNT1 cause different forms of bone fragility. Am J Hum Genet (2013) 1.39

Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130. Mol Cell (2003) 1.38

Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol Rev (2012) 1.38

The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J Immunol (2002) 1.38

Structure of the immunodominant surface antigen from the Toxoplasma gondii SRS superfamily. Nat Struct Biol (2002) 1.37

Mechanistic and structural insights into the proteolytic activation of Vibrio cholerae MARTX toxin. Nat Chem Biol (2009) 1.36

The refined crystal structure of an eel pout type III antifreeze protein RD1 at 0.62-A resolution reveals structural microheterogeneity of protein and solvation. Biophys J (2003) 1.36

Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1. Cell (2010) 1.35

Structure of a human A-type potassium channel interacting protein DPPX, a member of the dipeptidyl aminopeptidase family. J Mol Biol (2004) 1.34

An autonomous CDR3delta is sufficient for recognition of the nonclassical MHC class I molecules T10 and T22 by gammadelta T cells. Nat Immunol (2008) 1.33

Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc Natl Acad Sci U S A (2006) 1.32

Roles of glutamates and metal ions in a rationally designed nitric oxide reductase based on myoglobin. Proc Natl Acad Sci U S A (2010) 1.29

Structural insight into pre-B cell receptor function. Science (2007) 1.29

Long-range cooperative binding effects in a T cell receptor variable domain. Proc Natl Acad Sci U S A (2006) 1.26

Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions. J Exp Med (2002) 1.25

Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1. J Mol Biol (2005) 1.25

Evidence for a functional sidedness to the alphabetaTCR. Proc Natl Acad Sci U S A (2010) 1.24

High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J Mol Biol (2004) 1.21

The impact of TCR-binding properties and antigen presentation format on T cell responsiveness. J Immunol (2009) 1.20

A model T-cell receptor system for studying memory T-cell development. Microbes Infect (2003) 1.19

Simplified, enhanced protein purification using an inducible, autoprocessing enzyme tag. PLoS One (2009) 1.19

New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation. J Immunol (2009) 1.18

Staphylococcal superantigens cause lethal pulmonary disease in rabbits. J Infect Dis (2010) 1.18

Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc Natl Acad Sci U S A (2007) 1.17

Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex. Mol Cell (2008) 1.17